Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL)
CUSIP: 05280R100
Q2 2019 13F Holders as of 30 Jun 2019
- Type / Class
- Equity / American Depositary Shares, each representing one ordinary share, par value $0.000042 per share
- Shares outstanding
- 265,957,447
- Total 13F shares
- 21,383,578
- Share change
- +3,283,170
- Total reported value
- $344,232,698
- Price per share
- $16.10
- Number of holders
- 45
- Value change
- +$52,450,982
- Number of buys
- 33
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 05280R100?
CUSIP 05280R100 identifies AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 05280R100:
Top shareholders of AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Woodford Investment Management Ltd |
13F
|
Company |
4.5%
|
12,041,419
|
$378,944,000 | — | 31 Mar 2019 | |
| Tetragon Partners GP Ltd |
13F
|
Company |
0.32%
|
851,631
|
$26,801,000 | — | 31 Mar 2019 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.32%
|
850,000
|
$26,750,000 | — | 31 Mar 2019 | |
| Alphabet Inc. |
13F
|
Company |
0.27%
|
714,072
|
$22,472,000 | — | 31 Mar 2019 | |
| Capital World Investors |
13F
|
Company |
0.23%
|
611,112
|
$19,232,000 | — | 31 Mar 2019 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.2%
|
534,517
|
$16,821,000 | — | 31 Mar 2019 | |
| Capital International Investors |
13F
|
Company |
0.18%
|
488,888
|
$15,385,000 | — | 31 Mar 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.17%
|
450,362
|
$14,173,000 | — | 31 Mar 2019 | |
| Artal Group S.A. |
13F
|
Company |
0.17%
|
450,000
|
$14,162,000 | — | 31 Mar 2019 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.09%
|
232,931
|
$7,330,000 | — | 31 Mar 2019 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.07%
|
192,994
|
$6,074,000 | — | 31 Mar 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.07%
|
189,070
|
$5,951,000 | — | 31 Mar 2019 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.06%
|
156,773
|
$4,934,000 | — | 31 Mar 2019 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.03%
|
90,043
|
$2,834,000 | — | 31 Mar 2019 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.02%
|
49,260
|
$1,550,000 | — | 31 Mar 2019 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.02%
|
42,230
|
$1,329,000 | — | 31 Mar 2019 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.01%
|
39,245
|
$1,235,000 | — | 31 Mar 2019 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.01%
|
30,000
|
$944,000 | — | 31 Mar 2019 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0%
|
12,000
|
$378,000 | — | 31 Mar 2019 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0%
|
12,000
|
$378,000 | — | 31 Mar 2019 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
10,549
|
$332,000 | — | 31 Mar 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
9,811
|
$308,000 | — | 31 Mar 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0%
|
8,720
|
$274,000 | — | 31 Mar 2019 | |
| VIRTUS ADVISERS, LLC |
13F
|
Company |
0%
|
8,434
|
$265,000 | — | 31 Mar 2019 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0%
|
6,362
|
$200,000 | — | 31 Mar 2019 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
3,041
|
$96,000 | — | 31 Mar 2019 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
1,500
|
$47,000 | — | 31 Mar 2019 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
387
|
$12,000 | — | 31 Mar 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
300
|
$9,000 | — | 31 Mar 2019 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
265
|
$8,000 | — | 31 Mar 2019 | |
| Daiwa Securities Group Inc. |
13F
|
Company |
0%
|
115
|
$4,000 | — | 31 Mar 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
92
|
$2,000 | — | 31 Mar 2019 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
46
|
$1,000 | — | 31 Mar 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
42
|
$1,000 | — | 31 Mar 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
27
|
$1,000 | — | 31 Mar 2019 |
Institutional Holders of Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL) as of Q2 2019
As of 30 Jun 2019,
Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,383,578 shares.
The largest 10 holders included
Woodford Investment Management Ltd, Capital World Investors, PRICE T ROWE ASSOCIATES INC /MD/, Polygon Management Ltd., MILLENNIUM MANAGEMENT LLC, Cormorant Asset Management, LP, Alphabet Inc., MARSHALL WACE, LLP, Artal Group S.A., and Capital International Investors.
This page lists
45
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
32
Q2 2019 holders
45
Holder diff
13
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 Value $ | Q2 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.